For people who do not have diabetes, only semaglutide was associated with a reduction in depression and anxiety, compared to people who were not on GLP-1 medications
Sounds like you're really getting a handle on all this
Semaglutide (Wegovy) and liraglutide (Saxenda) are recommended within specialist weight management services for adults with a BMI of at least 35 kg/m (or 32.5 kg/m for people from South Asian, Chinese, other Asian, Middle Eastern, Black African, or African-Caribbean backgrounds) with at least one weight-related comorbidity
Bundle discounts apply for three-month and six-month plans for both medications
No matter your BMI, whether or not you had diabetes, we saw the beneficial effects of greater sensitivity for reducing the risk of outcomes in all subgroups, Hung said